Callan Family Office’s Novanta NOVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$727K Sell
4,482
-3,536
-44% -$511K 0.01% 691
2026
Q1
$947K Buy
8,018
+1,638
+26% +$215K 0.02% 576
2025
Q4
$759K Buy
6,380
+2,538
+66% +$289K 0.02% 630
2025
Q3
$385K Sell
3,842
-1,275
-25% -$152K 0.01% 622
2025
Q2
$660K Buy
5,117
+2,031
+66% +$247K 0.02% 500
2025
Q1
$395K Buy
3,086
+41
+1% +$5.89K 0.03% 376
2024
Q4
$465K Buy
+3,045
New +$516K 0.03% 382

Other funds holding NOVT

Callan Family Office's NOVT Position: Q2 2026 in Review

Callan Family Office reduced its Novanta (NOVT) stake by 44% in Q2 2026, selling an estimated $511K and leaving 4,482 shares worth $727K. The position accounts for 0.01% of the portfolio, ranked #691.

Callan Family Office first reported a position in NOVT in Q4 2024 and has held it in 7 quarters since. The position peaked at $947K in Q1 2026. 391 funds tracked by Wall St. Rank hold NOVT as of Q2 2026.

  • Callan Family Office held 4,482 shares of Novanta worth $727K as of Q2 2026.
  • Callan Family Office sold 3,536 Novanta shares in Q2 2026, an estimated $511K.
  • Novanta made up 0.01% of Callan Family Office's portfolio in Q2 2026, its #691 holding.
  • Callan Family Office first reported a position in Novanta in Q4 2024 and has held it in 7 quarters since.
  • Callan Family Office's Novanta position peaked at $947K in Q1 2026.
  • 391 funds tracked by Wall St. Rank held Novanta as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.